Driver mutations such as SF3B1 commonly seen in CLL tumors are also present in CLL patient bone marrow CD34+CD19- HSCs (1, 18, 19, 29) and MBL patient B cells (22, 30, 31). This evidence concerns the gene SF3B1 and B-cell chronic lymphocytic leukemia.